Series Description: 

This is a twice-monthly conference moderated by medical oncology, radiation oncology, surgery, radiology and/or pathology specialists and attended by community practitioners affiliated with Sutter Delta Medical Center. Specific patient cases are discussed and are generally related to oncology and hematology diagnoses, screening, treatment (including clinical trials), prognosis, follow-up, palliative/hospice care, survivorship and mortality/morbidity issues. Selected patients are currently admitted to Sutter Delta Hospital or use outpatient services at the hospital as part of their diagnostic work-up, screening and/or treatment. Cases are presented in a confidential, HIPAA compliant manner.

Target Audience: 

Physicians (MD or DO)

Other Healthcare Professionals

Learning Objectives- After Attending this Activity, Learners Should be Able to:

1. Identify and explore oncology screening guidelines and screening tools and technology available to general and high-risk patients in the community. This includes references to guidelines from various oncology organizations including ASTRO, ASCO and NCCN.
2. Discuss appropriate diagnostic work-up and treatment guidelines. for certain hematologic and solid tumor malignancies, including the importance of physical exam and how to use radiology, cytology, pathology, next-generation sequencing, molecular profiling, tumor typing and genomic testing in the diagnosis and treatment of cancer. This includes references to guidelines from various oncology organizations including ASTRO, ASCO and NCCN.
3. Discuss and explore the latest developments in cancer therapy, pain management and palliative/hospice care and support and rehabilitative services for patients in the community.
4. Discuss and highlight disparities in oncology screening and care in the community.

Providing Culturally Appropriate Care which is Free of Implicit Biases (AB 1195 & 241):

Learners are strongly encouraged to engage in self-directed learning related to the impact of implicit biases in this clinical area via the references provided below:

SDoH/Implicit Bias 

1. Tucker-Seely et al (2024). Social Determinants of health and cancer care: An ASCO Policy Statement.  JCO Oncol Prac 20(5): 621-630. DOI: 10.1200/OP.23.00810
2. Schatz et al (2022). Patient, caregiver and oncologist experiences with and perceptions of racial bias and discrimination in cancer care delivery.  J Natl Compr Canc Netw 20(10); 1092-1098.e2.  doi: 10.6004/jnccn.2022.705

Disclosure of Financial or In-Kind Commercial Support & Conflict of Interest

No one involved in the planning or presentation of this educational activity have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. No financial or in-kind commercial support was received to produce or promote this educational activity.   

– Provider Designee/Verification:  Fozia Ferozali, Ed.D.
 

Faculty List: 

Planner(s)
Nicola Ally, MD has no relevant financial relationships to disclose at this time. 
Jaspreet Kaur has no relevant financial relationships to disclose at this time. 
Prasad Pillai has no relevant financial relationships to disclose at this time.
Margaret Seaver has no relevant financial relationships to disclose at this time.
John Van Uden, MD, PhD has no relevant financial relationships to disclose at this time.
Tony Yang, MD, PhD has no relevant financial relationships to disclose at this time.

Speaker(s)
Nicola Ally, MD has no relevant financial relationships to disclose at this time.
Prasad Pillai has no relevant financial relationships to disclose at this time.
Margaret Seaver has no relevant financial relationships to disclose at this time.
John Van Uden, MD, PhD has no relevant financial relationships to disclose at this time.
Tony Yang, MD, PhD has no relevant financial relationships to disclose at this time.